We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type |
---|---|---|---|
Arrowhead Pharmaceuticals Inc | NASDAQ:ARWR | NASDAQ | Common Stock |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.55 | 2.43% | 23.17 | 22.87 | 23.85 | 23.84 | 22.62 | 22.72 | 1,113,561 | 22:30:00 |
SAN DIEGO and PASADENA, Calif., Jan. 14, 2015 /PRNewswire/ -- Shareholder rights law firm Robbins Arroyo LLP is investigating whether certain officers and directors of Arrowhead Research Corporation (NASDAQGS: ARWR) breached their fiduciary duties to shareholders. Arrowhead is a biopharmaceutical company that develops targeted RNAi therapeutics in the United States.
View this press release on the law firm's Shareholder Rights Blog: www.robbinsarroyo.com/shareholders-rights-blog/arrowhead-research-corporation
Arrowhead to Cut Hepatitis B Drug Study Dosage in Mid-Stage Trial
On January 12, 2015, Arrowhead stock fell over 23% to close at $6.90 per share after the company announced that the U.S. Food and Drug Administration verbally informed the company of a partial clinical hold on its ARC-520 study for patients with chronic hepatitis B. The FDA has informed Arrowhead that it will need to start a new, multi-dose study at one mg/kg instead of the proposed two and four mg/kg. In addition, the FDA has requested additional information from the drug's current mid-stage study.
Arrowhead Shareholders Have Legal Options
Concerned shareholders who would like more information about their rights and potential remedies can contact attorney Darnell R. Donahue at (800) 350-6003, DDonahue@robbinsarroyo.com, or via the shareholder information form on the firm's website.
Robbins Arroyo LLP is a nationally recognized leader in shareholder rights law. The firm represents individual and institutional investors in shareholder derivative and securities class action lawsuits, and has helped its clients realize more than $1 billion of value for themselves and the companies in which they have invested.
Attorney Advertising. Past results do not guarantee a similar outcome.
Contact:
Darnell R. Donahue
Robbins Arroyo LLP
600 B Street, Suite 1900
San Diego, Ca 92101
DDonahue@robbinsarroyo.com
(619) 525-3990 or Toll Free (800) 350-6003
www.robbinsarroyo.com
Logo - http://photos.prnewswire.com/prnh/20130103/MM36754LOGO
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/robbins-arroyo-llp-is-investigating-the-officers-and-directors-of-arrowhead-research-corporation-arwr-on-behalf-of-shareholders-300020753.html
SOURCE Robbins Arroyo LLP
Copyright 2015 PR Newswire
1 Year Arrowhead Pharmaceuticals Chart |
1 Month Arrowhead Pharmaceuticals Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions